[心力衰竭的医疗治疗中确立了什么?]
Samira Soltani, Johann Bauersachs1
1Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. bauersachs.johann@mh-hannover.de.
Innere Medizin (Heidelberg, Germany)
|October 8, 2025
概括
心力衰竭的治疗因射出分数而异. 以指导方针为导向的医疗疗,包括RNAI,β-阻断剂,MRA和SGLT2抑制剂,改善了减少射出分数心力衰竭 (HFrEF) 的结果. HFpEF管理侧重于症状和并发症.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 心力衰竭 (HF) 的治疗因左心室喷射率 (LVEF) 而有显著的变化,这对临床提出了重大挑战.
- 患者被分为减少的 (HFrEF),轻度减少的 (HFmrEF) 或保存的喷射分数 (HFpEF).
研究的目的:
- 总结目前针对不同类型心力衰竭的基于证据的治疗策略.
- 突出关键的治疗药物及其对死亡率和住院治疗的影响.
主要方法:
- 审查当前的临床指南和里程碑研究.
- 对HFrEF/HFmrEF和HFpEF的治疗建议的分析.
- 包括关于新型治疗剂和支持性干预措施的数据.
主要成果:
- 对于HFrEF/HFmrEF,包括RNAI,β-抑制剂,MRA和SGLT2抑制剂在内的指南导向医疗疗 (GDMT) 显著降低了死亡率和住院病例.
- 静脉注射铁补充剂改善了运动能力,并减少了HFrEF铁缺乏症患者的住院治疗.
- 在HFpEF中,利尿剂可以控制体积过载,推使用SGLT2抑制剂,而新型药物如菲内伦显示出有前途.
- 代谢向疗法,如GLP-1受体激动剂,对于肥胖的HFpEF患者来说越来越重要.
结论:
- 全面实施GDMT对于改善HFrEF的预后至关重要.
- 高血压表的管理需要缓解症状,控制并发病症,并考虑新兴疗法.
- 基于LVEF和患者特征的个性化治疗方法对于最佳的心力衰竭护理至关重要.
更多相关视频
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
7.0K
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
12.4K
相关概念视频
01:30Heart Failure V: Medical Management
218
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
218
01:22Heart Failure VI: Adjunct Therapies
255
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255
01:30Heart Failure VII: Nursing Interventions
416
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
416
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932
01:30Heart Failure IV: Classification and Diagnostic Evaluation
319
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
319
01:21Rheumatic Heart Disease III: Medical Management
285
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
285